Evaluation of Antibiotic Utilization in Urinary Tract Infection Patients Using Gyssens Method
Abstract
UTI is one of the most prevalent infections in Indonesia, with a prevalence rate of 15%. Antibiotic resistance complicates UTI treatment. Assessing antibiotic use can help prevent the development of antibiotic resistance. This study analyses the characteristics and profile of UTI patients at Dr Drajat Prawiranegara in 2022 and evaluates antibiotic use based on Gyssens' guidelines. For this investigation, 50 medical records were consecutively sampled. This study reported that 46% of patients were male and 64% female. Patients were 0-5 years (6%), 12-16 years (4%), 17-25 years (12%), 26-35 years (28%), 36-45 years (12%), 46-55 years (16%), 56-65 years (10%), and over 65 years (10%) old. Medical records showed that ceftriaxone (43%), levofloxacin (31%), cefotaxime (16%), cefoperazone (4.1%), and cefoperazone-sulbactam (4.1%) were the most commonly administered antibiotics. All patients received IV antibiotics. The Gyssens technique found that 74% of patients used antibiotics rationally. The remaining 26% use antibiotics irrationally, with differences within each category. This study found that most UTI patients at RSUD Dr Drajat Prawiranegara received medications logically. However, age, gender, medical history, and health problems can impact antibiotic use. For more representative and thorough results, bigger sample sizes and multidisciplinary teams are recommended.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.